首页 | 本学科首页   官方微博 | 高级检索  
检索        


De-escalation of five-year adjuvant endocrine therapy in patients with estrogen receptor-low positive (immunohistochemistry staining 1%-10%) breast cancer: Propensity-matched analysis from a prospectively maintained cohort
Authors:Yu-Wen Cai MD  Zhi-Ming Shao MD  Ke-Da Yu MD  PhD
Institution:1. Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China

Shanghai Medical College, Fudan University, Shanghai, China;2. Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China

Shanghai Key Laboratory of Breast Cancer, Shanghai, China;3. Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China

Abstract:
Keywords:breast cancer  endocrine therapy  estrogen receptor low-positive  short-term
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号